Search JTA's historical archive dating back to 1923

News Brief

October 19, 2001
See Original Daily Bulletin From This Date

Israel-based Teva Pharmaceuticals is one of five drug makers ready to produce generic versions of Cipro to help boost U.S. reserves of the antibiotic used to treat anthrax, the Jerusalem Post reported. Bayer, which has more than tripled its production of Cipro, said it was considering asking for help from manufacturers of generic drugs. Other antibiotics, including penicillin, also have been approved for anthrax treatment.

Recommended from JTA